Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Selank (TP-7)
Selank is a synthetic analog of the immunomodulatory peptide tuftsin. It has been studied for anxiolytic and nootropic effects and is approved in Russia as a treatment for anxiety disorders.
Selank modulates the GABAergic system, influences serotonin metabolism, and has been shown to affect BDNF expression. It may also have immunomodulatory properties through its tuftsin-related structure.
Approved in Russia as a prescription anxiolytic nasal spray. Clinical studies show reductions in generalized anxiety comparable to benzodiazepines but without sedation or cognitive impairment. It also demonstrates immunomodulatory and nootropic effects in preclinical models.
Typical Dose
300mcg
Range
200-500mcg
Frequency
2x/day (intranasal or subcutaneous)
Route
Nasal or SubQ
Duration
2-4 weeks
Reconstitution
5mg vial + 2mL bacteriostatic water = 2,500mcg/mL
Notes
Nasal spray is the most common administration route. Typical cycles run 2–4 weeks. No significant tolerance or withdrawal has been documented in clinical use.
These biomarkers are commonly tracked to assess response and safety. Run baseline labs before starting, mid-cycle labs halfway through, and post-cycle labs 1–2 weeks after the final dose.
Build a protocol with Selank, schedule blood work for key biomarkers, and track your results.
Build Protocol with SelankThis platform provides informational tools only, not medical advice. This information is for educational purposes only. Consult a licensed provider.
Disclosed Labs